Conditions
One sample, many conditions.
A single Q-Pad collection event opens diagnostic access across cervical cancer and STIs, endometriosis, heavy menstrual bleeding, the menopause transition, fertility and hormones, and gynecologic cancers. Each condition has its own page covering care path, existing science, and Qvin's working role.
Browse conditions
Six conditions, one infrastructure.
-
Cervical cancer · STIs · BV
Gynecologic infection screening on a single sample.
-
Endometriosis
A disease defined by diagnostic delay — and by misplaced endometrial tissue.
-
Heavy menstrual bleeding
The most common reason women see a gynecologist — still managed without molecular tools.
-
Menopause transition
A decade of physiology with virtually no longitudinal monitoring.
-
Fertility & hormones
Repeated, at-home, multi-marker hormonal monitoring without phlebotomy.
-
Endometrial cancer
A gynecologic cancer with no screening test — and the tissue of origin in the menstrual sample.
Cross-cutting research
Programs that cut across condition silos.
Two large institutional collaborations operate at the level of menstrual biology rather than a single condition:
- Statens Serum Institut (CYCLOME) — Wellcome Leap–funded program characterizing the cyclical proteome and methylome of menstrual blood across thousands of participants.
- Stanford University (iPOP) — multi-omic deep phenotyping using menstrual blood as a recurring at-home sample, in the Snyder Lab tradition.
Mayo Clinic, the University of Exeter, and other research partners contribute condition-specific work referenced on the per-condition pages. See Commercial for how partnerships are structured.